Sign In
Buy QBIO
$0.0001
+0 (+0%)
At Close: Jun 02, 2026
Q BioMed announces up to $30M investment from insider, allowing it to advance company's growth plans
11:10am, Tuesday, 11'th May 2021
Q BioMed Inc (OTCQB:QBIO) has unveiled its largest single investment so far, with Aedesius Holdings Ltd (AedesiusOne), a privately held global disruption aggregator, investing up to $30 million in th
Q BioMed touts development progress of coronavirus treatment MAN-19 and other therapies in letter to shareholders
12:11pm, Tuesday, 27'th Apr 2021
Q BioMed Inc (OTCQB:QBIO) has released a letter to shareholders, bringing them up to speed on the developments of its technology partner, Mannin Research, and its work to treat the coronavirus (COVID-
Q BioMed Updates Shareholders
07:30am, Tuesday, 27'th Apr 2021
NEW YORK, April 27, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, updates shareholders. In March 2021,it was announced that our technology partner, Mannin Rese
Q BioMed has a winner in cancer bone pain drug Strontium89 and a deep pipeline of biomedical assets
01:07pm, Friday, 12'th Mar 2021
Acquires undervalued biomedical assets to accelerate their development Developing drugs and therapies to treat pediatric nonverbal autism, liver cancer, and glaucoma Produces cancer bone-pain drug Str
US stocks mixed at open as traders look for direction
10:32am, Tuesday, 02'nd Mar 2021
10.25am: Proactive North America headlines: Tartisan Nickel Corp (CSE:TN) (OTCMKTS:TTSRF) (FRA:8TA) poised for geophysical survey at flagship Kenbridge nickel-copper-cobalt project Psyched Wellness Lt
Q BioMed announces five year contract with the US Department of Defense and Veterans Affairs for its cancer bone pain drug
09:07am, Tuesday, 02'nd Mar 2021
Q BioMed Inc (OTCQB:QBIO) has announced a supply contract with the US Department of Defense and Veterans Affairs (VA), which will make its cancer bone pain drug available to over 9 million VA benefici
Q BioMed's Uttroside-B Receives U.S. FDA Orphan Drug Designation in the Treatment of Liver Cancer
07:30am, Wednesday, 27'th Jan 2021
NEW YORK, Jan. 27, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), announced today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designat
